Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
Discharge	O
Summary	O

Sample	O
Name	O
:	O
Multiple	O
Medical	O
Problems	O
-	O
Discharge	O
Summary	O

Description	O
:	O
Seizure	B-problem
,	O
hypoglycemia	B-problem
,	O
anemia	B-problem
,	O
dyspnea	B-problem
,	O
edema	B-problem
.	O

colon	B-bodyloc
cancer	I-problem
status	O
post	B-treatment
right	I-treatment
hemicolectomy	I-treatment
,	O
hospital	B-problem
-	I-problem
acquired	I-problem
pneumonia	I-problem
,	O

and	O
congestive	B-problem
heart	B-bodyloc
failure	I-problem
.	O

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

ADMISSION	O
DIAGNOSES	O
:	O

1	O
.	O

Seizure	B-problem
.	O

2	O
.	O

Hypoglycemia	B-problem
.	O

3	O
.	O

Anemia	B-problem
.	O

4	O
.	O

Hypotension	B-problem
.	O

5	O
.	O

Dyspnea	B-problem
.	O

6	O
.	O

Edema	B-problem
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1	O
.	O

Colon	B-bodyloc
cancer	I-problem
,	O
status	O
post	B-treatment
right	I-treatment
hemicolectomy	I-treatment
.	O

2	O
.	O

Anemia	B-problem
.	O

3	O
.	O

Hospital	B-problem
-	I-problem
acquired	I-problem
pneumonia	I-problem
.	O

4	O
.	O

Hypertension	B-problem
.	O

5	O
.	O

Congestive	B-problem
heart	B-bodyloc
failure	I-problem
.	O

6	O
.	O

Seizure	B-problem
disorder	I-problem
.	O

PROCEDURES	O
PERFORMED	O
:	O

1	O
.	O

Colonoscopy	B-test
.	O

2	O
.	O

Right	B-treatment
hemicolectomy	I-treatment
.	O

HOSPITAL	O
COURSE	O
:	O
The	O
patient	O
is	O
a	O
59	O
-	O
year	O
-	O
old	O
female	O
with	O
multiple	B-problem
medical	I-problem
problems	I-problem
including	O
diabetes	B-problem
mellitus	I-problem
requiring	O
insulin	B-drug
for	B-frequency
26	I-frequency
years	I-frequency
,	O
previous	B-problem
MI	I-problem
and	O
coronary	B-problem
artery	B-bodyloc
disease	I-problem
,	O
history	O
of	O
seizure	B-problem
disorder	I-problem
,	O
GERD	B-problem
,	O
bipolar	B-problem
disorder	I-problem
,	O
and	O
anemia	B-problem
.	O

She	O
was	O
admitted	O
due	O
to	O
a	B-problem
seizure	I-problem
and	O
myoclonic	B-problem
jerks	O
as	O
well	O
as	O
hypoglycemia	B-problem
and	O
anemia	B-problem
.	O

Regarding	O
the	O
seizure	B-problem
disorder	I-problem
,	O
Neurology	O
was	O
consulted	O
.	O

Noncontrast	B-test
CT	I-test
of	I-test
the	I-test
head	I-test
was	O
negative	B-labvalue
.	O

Neurology	O
felt	O
that	O
the	O
only	O
necessary	O
intervention	O
at	O
that	O
time	O
would	O
be	O
to	O
increase	O
her	B-drug
Lamictal	I-drug
to	O
150	B-strength
mg	I-strength
in	B-frequency
the	I-frequency
morning	I-frequency
and	O
100	B-strength
mg	I-strength
in	B-frequency
the	I-frequency
evening	I-frequency
with	O
gradual	O
increase	O
of	O
the	O
dosage	O
until	O
she	O
was	O
on	O
200	B-strength
mg	I-strength
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	O

Regarding	O
the	B-problem
hypoglycemia	I-problem
,	O
the	O
patient	O
has	O
diabetic	B-problem
gastroparesis	I-problem
and	O
was	O
being	O
fed	O
on	O
J	B-treatment
-	I-treatment
tube	I-treatment
intermittent	I-treatment
feedings	I-treatment
throughout	O
the	O
night	O
at	O
the	B-test
rate	I-test
of	O
120	B-labvalue
an	O
hour	O
.	O

Her	B-drug
insulin	I-drug
pump	I-drug
had	O
a	O
basal	O
rate	O
of	O
roughly	O
three	O
at	O
night	O
during	O
the	B-treatment
feedings	I-treatment
.	O

While	O
in	O
the	O
hospital	O
,	O
the	B-drug
insulin	I-drug
pump	I-drug
rate	O
was	O
turned	O
down	O
to	O
1	B-dosage
.	I-dosage
5	I-dosage
and	O
then	O
subsequently	O
decreased	O
a	O
few	O
other	O
times	O
.	O

She	O
seemed	O
to	O
tolerate	O
the	B-drug
insulin	I-drug
pump	O
rate	O
well	O
throughout	O
her	O
hospital	O
course	O
.	O

There	O
were	O
a	B-problem
few	I-problem
episodes	I-problem
of	I-problem
hypoglycemia	I-problem
as	O
well	O
as	O
hyperglycemia	B-problem
,	O
but	O
the	O
episode	O
seem	O
to	O
be	O
related	O
to	O
the	O
patient	O
'	O
s	O
n	O
.	O
p	O
.	O
o	O
.	O
status	O
and	O
the	O
changing	O
rates	O
of	O
tube	B-treatment
feedings	I-treatment
throughout	O
her	O
hospital	O
course	O
.	O

At	O
discharge	O
,	O
her	O
endocrinologist	O
was	O
contacted	O
.	O

It	O
was	O
decided	O
to	O
change	O
her	B-drug
insulin	I-drug
pump	O
rate	O
to	O
3	B-strength
units	I-strength
per	B-frequency
hour	I-frequency
from	O
midnight	B-temporal
till	I-temporal
6	I-temporal
a	I-temporal
.	I-temporal
m	I-temporal
.	I-temporal
,	O
from	O
0	B-strength
.	I-strength
8	I-strength
units	I-strength
per	B-frequency
hour	I-frequency
from	O
6	B-temporal
a	I-temporal
.	I-temporal
m	I-temporal
.	I-temporal
until	I-temporal
8	I-temporal
a	I-temporal
.	I-temporal
m	I-temporal
.	I-temporal
,	O
and	O
then	O
at	O
0	B-strength
.	I-strength
2	I-strength
units	I-strength
per	B-frequency
hour	I-frequency
from	O
8	B-temporal
a	I-temporal
.	I-temporal
m	I-temporal
.	I-temporal
until	I-temporal
6	I-temporal
p	I-temporal
.	I-temporal
m	I-temporal
.	O

The	B-drug
insulin	I-drug
was	O
to	O
be	O
NovoLog	B-drug
.	O

Regarding	O
the	B-problem
anemia	I-problem
,	O
the	O
gastroenterologists	O
were	O
consulted	O
regarding	O
her	B-problem
positive	I-problem
Hemoccult	I-problem
stools	I-problem
.	O

A	B-test
colonoscopy	I-test
was	O
performed	O
,	O
which	O
found	O
a	B-problem
mass	I-problem
at	I-problem
the	I-problem
right	I-problem
hepatic	I-problem
flexure	I-problem
.	O

General	O
Surgery	O
was	O
then	O
consulted	O
and	O
a	B-treatment
right	I-treatment
hemicolectomy	I-treatment
was	O
performed	O
on	O
the	O
patient	O
.	O

The	O
patient	O
tolerated	O
the	B-treatment
procedure	I-treatment
well	O
and	O
tube	B-treatment
feeds	I-treatment
were	O
slowly	O
restarted	O
following	O
the	B-treatment
procedure	I-treatment
,	O
and	O
prior	O
to	O
discharge	O
were	O
back	O
at	O
her	O
predischarge	O
rates	O
of	O
120	O
per	O
hour	O
.	O

Regarding	O
the	B-problem
cancer	I-problem
itself	O
,	O
it	O
was	O
found	O
that	O
1	O
out	O
of	O
53	O
nodes	O
were	O
positive	O
for	O
cancer	B-problem
.	O

CT	B-test
of	I-test
the	I-test
abdomen	I-test
and	I-test
pelvis	I-test
revealed	O
no	B-negation
metastasis	B-problem
,	O
a	B-test
CT	I-test
of	I-test
the	I-test
chest	I-test
revealed	O
possible	O
lung	B-problem
metastasis	I-problem
.	O

Later	O
in	O
hospital	O
course	O
,	O
the	O
patient	O
developed	O
a	B-problem
septic	I-problem
-	I-problem
like	I-problem
picture	I-problem
likely	O
secondary	O
to	O
hospital	B-problem
-	I-problem
acquired	I-problem
pneumonia	I-problem
.	O

She	O
was	O
treated	O
with	O
Zosyn	B-drug
,	O
Levaquin	B-drug
,	O
and	O
vancomycin	B-drug
,	O
and	O
tolerated	O
the	B-drug
medications	I-drug
well	O
.	O

Her	B-problem
symptoms	I-problem
decreased	O
and	O
serial	B-test
chest	I-test
x	I-test
-	I-test
rays	I-test
were	O
followed	O
,	O
which	O
showed	O
some	O
resolution	O
of	O
the	B-problem
illness	I-problem
.	O

The	O
patient	O
was	O
seen	O
by	O
the	O
Infectious	O
Disease	O
specialist	O
.	O

The	O
Infectious	O
Disease	O
specialist	O
recommended	O
vancomycin	B-drug
to	O
cover	O
MRSA	B-problem
bacteria	I-problem
,	O
which	O
was	O
found	O
at	O
the	B-treatment
J	I-treatment
-	I-treatment
tube	I-treatment
site	I-treatment
.	O

At	O
discharge	O
,	O
the	O
patient	O
was	O
given	O
three	O
additional	O
days	O
of	O
p	O
.	O
o	O
.	O

Levaquin	B-drug
750	B-strength
mg	I-strength
as	O
well	O
as	O
three	O
additional	O
days	O
of	O
Bactrim	B-drug
DS	I-drug
every	B-frequency
12	I-frequency
hours	I-frequency
.	O

The	B-drug
Bactrim	I-drug
was	O
used	O
to	O
cover	O
the	B-problem
MRSA	I-problem
at	O
the	B-treatment
J	I-treatment
-	I-treatment
tube	I-treatment
site	I-treatment
.	O

It	O
was	O
found	O
that	O
MRSA	B-problem
was	O
sensitive	O
to	O
Bactrim	B-drug
.	O

Throughout	O
her	O
hospital	O
course	O
,	O
the	O
patient	O
continued	O
to	O
receive	O
Coreg	B-drug
12	B-strength
.	I-strength
5	I-strength
mg	I-strength
daily	B-frequency
and	O
Lasix	B-drug
40	B-strength
mg	I-strength
twice	B-frequency
a	I-frequency
day	I-frequency
for	O
her	B-problem
congestive	I-problem
heart	B-bodyloc
failure	I-problem
,	O
which	O
remains	O
stable	O
.	O

She	O
also	O
received	O
Lipitor	B-drug
for	O
her	B-problem
high	I-problem
cholesterol	I-problem
.	O

Her	B-problem
seizure	I-problem
disorder	I-problem
remained	O
stable	O
and	O
she	O
was	O
discharged	O
on	O
a	O
dose	O
of	O
100	O
mg	O
in	O
the	O
morning	O
and	O
150	O
mg	O
at	O
night	O
.	O

The	O
dosage	O
increases	O
can	O
begin	O
on	O
an	O
outpatient	O
basis	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
/	O
MEDICATIONS	O
:	O
The	O
patient	O
was	O
discharged	O
to	O
home	O
.	O

She	O
was	O
told	O
to	O
shy	O
away	O
from	O
strenuous	O
activity	O
.	O

Her	O
discharge	O
diet	O
was	O
to	O
be	O
her	O
usual	O
diet	O
of	O
isotonic	B-treatment
fiber	I-treatment
feeding	I-treatment
through	O
the	B-treatment
J	I-treatment
-	I-treatment
tube	I-treatment
at	O
a	O
rate	O
of	O
120	O
per	O
hour	O
throughout	O
the	O
night	O
.	O

The	B-drug
discharge	I-drug
medications	I-drug
were	O
as	O
follows	O
:	O

1	O
.	O

Coreg	B-drug
12	B-strength
.	I-strength
5	I-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

2	O
.	O

Lipitor	B-drug
10	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
at	B-frequency
bedtime	I-frequency
.	O

3	O
.	O

Nitro	B-drug
-	I-drug
Dur	I-drug
patch	B-form
0	B-strength
.	I-strength
3	I-strength
mg	I-strength
per	I-strength
hour	I-strength
one	B-dosage
patch	B-form
daily	B-frequency
.	O

4	O
.	O

Phenergan	B-drug
syrup	B-form
6	B-strength
.	I-strength
25	I-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
q	B-frequency
.	I-frequency
4h	I-frequency
.	I-frequency
p	B-frequency
.	I-frequency
r	I-frequency
.	I-frequency
n	I-frequency
.	I-frequency

5	O
.	O

Synthroid	B-drug
0	B-strength
.	I-strength
175	I-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
.	O

6	O
.	O

Zyrtec	B-drug
10	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
.	O

7	O
.	O

Lamictal	B-drug
100	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
daily	B-frequency
.	O

8	O
.	O

Lamictal	B-drug
150	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
at	B-frequency
bedtime	I-frequency
.	O

9	O
.	O

Ferrous	B-drug
sulfate	I-drug
drops	B-form
325	B-strength
mg	I-strength
,	O
PEG	B-treatment
tube	I-treatment
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	O

10	O
.	O

Nexium	B-drug
40	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
at	B-frequency
breakfast	I-frequency
.	O

11	O
.	O

Neurontin	B-drug
400	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

12	O
.	O

Lasix	B-drug
40	B-strength
mg	I-strength
p	B-route
.	I-route
o	I-route
.	I-route
b	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

13	O
.	O

Fentanyl	B-drug
50	B-strength
mcg	I-strength
patch	B-form
transdermal	B-route
q	B-frequency
.	I-frequency
72h	I-frequency
.	I-frequency

14	O
.	O

Calcium	B-drug
and	I-drug
vitamin	I-drug
D	I-drug
combination	I-drug
,	O
calcium	B-drug
carbonate	I-drug
500	B-strength
mg	I-strength
/	O
vitamin	B-drug
D	I-drug
200	B-strength
units	I-strength
one	B-dosage
tab	B-form
p	B-route
.	I-route
o	I-route
.	I-route
t	B-frequency
.	I-frequency
i	I-frequency
.	I-frequency
d	I-frequency
.	I-frequency

15	O
.	O

Bactrim	B-drug
DS	I-drug
800mg	B-strength
/	I-strength
160	I-strength
mg	I-strength
tablet	B-form
one	B-dosage
tablet	B-form
q	B-frequency
.	I-frequency
12h	I-frequency
.	I-frequency
x3	B-duration
days	I-duration
.	O

16	O
.	O

Levaquin	B-drug
750	B-strength
mg	I-strength
one	B-dosage
tablet	B-form
p	B-route
.	I-route
o	I-route
.	I-route
x3	B-duration
days	I-duration
.	O

The	B-drug
medications	I-drug
listed	O
above	O
,	O
one	O
listed	O
as	O
p	O
.	O
o	O
.	O
are	O
to	O
be	O
administered	O
via	O
the	B-treatment
J	I-treatment
-	I-treatment
tube	I-treatment
.	O

FOLLOWUP	O
:	O
The	O
patient	O
was	O
instructed	O
to	O
see	O
Dr	O
.	O
X	O
in	O
approximately	O
five	O
to	O
seven	O
days	O
.	O

She	O
was	O
given	O
a	O
lab	O
sheet	O
to	O
have	O
a	B-test
CBC	I-test
with	I-test
diff	I-test
as	O
well	O
as	O
a	B-test
CMP	I-test
to	O
be	O
drawn	O
prior	O
to	O
her	O
appointment	O
with	O
Dr	O
.	O
X	O
.	O

She	O
is	O
instructed	O
to	O
follow	O
up	O
with	O
Dr	O
.	O
Y	O
if	O
her	O
condition	O
changes	O
regarding	O
her	B-problem
colon	B-bodyloc
cancer	I-problem
.	O

She	O
was	O
instructed	O
to	O
follow	O
up	O
with	O
Dr	O
.	O
Z	O
,	O
her	O
oncologist	O
,	O
regarding	O
the	B-problem
positive	I-problem
lymph	B-bodyloc
nodes	I-bodyloc
.	O

We	O
were	O
unable	O
to	O
contact	O
Dr	O
.	O
Z	O
,	O
but	O
his	O
telephone	O
number	O
was	O
given	O
to	O
the	O
patient	O
and	O
she	O
was	O
instructed	O
to	O
make	O
a	O
followup	O
appointment	O
.	O

She	O
was	O
also	O
instructed	O
to	O
follow	O
up	O
with	O
her	O
endocrinologist	O
,	O
Dr	O
.	O
A	O
,	O
regarding	O
any	B-drug
insulin	I-drug
pump	I-drug
adjustments	O
,	O
which	O
were	O
necessary	O
and	O
she	O
was	O
also	O
instructed	O
to	O
follow	O
up	O
with	O
Dr	O
.	O
B	O
,	O
her	O
gastroenterologist	O
,	O
regarding	O
any	B-problem
issues	I-problem
with	O
her	B-treatment
J	I-treatment
-	I-treatment
tube	I-treatment
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O
Stable	O
.	O

Keywords	O
:	O

discharge	O
summary	O
,	O
seizure	B-problem
,	O
hypoglycemia	B-problem
,	O
anemia	B-problem
,	O
dyspnea	B-problem
,	O
edema	B-problem
.	O

colon	B-problem
cancer	I-problem
status	O
post	B-treatment
right	I-treatment
hemicolectomy	I-treatment
,	O
hospital	O
-	O
acquired	O
pneumonia	B-problem
,	O
hospital	O
acquired	O
pneumonia	B-problem
,	O
congestive	B-problem
heart	I-problem
failure	I-problem
,	O
seizure	B-problem
disorder	I-problem
,	O
insulin	B-drug
pump	I-drug
,	O
hemicolectomy	B-treatment
,	O
neurology	O
,	O
disorder	B-problem
,	O

